Extended interview: FDA chief calls warnings on menopause treatments an “American tragedy”

[ad_1] Extended interview: FDA chief calls warnings on menopause treatments an “American tragedy” – CBS News Watch CBS News FDA Commissioner Dr. Marty Makary tells CBS News’ Norah O’Donnell in an exclusive interview why the agency decided to drop decades-old “black box” warnings on many hormone therapy drugs used for menopause and perimenopause symptoms. [ad_2]…

Read More

FDA chief says warning labels deterred women from using menopause hormone therapy: “It’s an American tragedy”

[ad_1] The U.S. Food and Drug Administration will remove the “black box” warning labels on many hormone therapy drugs used for menopause and perimenopause symptoms — a major turnaround that’s likely to encourage more women to seek treatment. FDA Commissioner Dr. Marty Makary said in an exclusive CBS News interview that the change ends a…

Read More

Promising clinical trials in Alzheimer’s prevention

[ad_1] Recent studies have shown new antibody drugs to slow cognitive decline among people with early-onset Alzheimer’s – a critical finding, given that the disease as of now has no cure. CBS News chief medical correspondent Dr. Jon LaPook visits Washington University School of Medicine in St. Louis, which is conducting important research into treating…

Read More

Promising clinical trials in Alzheimer’s prevention

[ad_1] “I just know that my brain’s not right,” said Carrie Richardson, 44. “And so, I hate it. I just want it to be normal.” At 41, Carrie developed early-onset Alzheimer’s disease. The condition is caused by rare genetic mutations that essentially guarantee a person will develop the disease. Her mother, Mary Salter, of Montgomery,…

Read More